It was reported that a patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced a cardiac tamponade treated with a pericardiocentesis.Atrial septal puncture was performed.Ablation was performed only for cavotricuspid ishmus (cti) at 40w before pericardial effusion or tamponade was confirmed.Box isolation was performed with cryo ablation catheter.Steam pop was not confirmed.There was no decrease in patient¿s blood pressure etc.In the final phase of the procedure, additional doses of adetphos were administered.After the additional doses, the patient's st increased sharply.After adetphos was administered, the patient's blood pressure dropped to the 40s.Coronary angiography (cag) was performed, nitroglycerin was administered, the patient¿s blood pressure decreased, and the pericardial effusion was confirmed by echocardiography.Pericardial drainage was performed, and the patient left the room to intensive care unit (icu).The physician's opinions on the relationship between the event and the product is that it was unclear whether the perforation was in the right or left atrium.The causal relationship was also unclear.Radiology records: cti 14:04~, adetphos was administered 14:15.13:18 the patient¿s heart rate was confirmed.14:11 it was confirmed the patient¿s heart rate decreased.14:40 the pericardial effusion was confirmed.No abnormalities observed prior to or during use of the product.
|
Device investigation details: the device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device number lot 31173570l and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|